Analytical Data
-
Gene name
ZNF10
- Application
-
Alternative Names
KOX1
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P21506
-
Expression Region
Met1~Asp244
-
Molecular Weight
32kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZNF10, also known as Zinc Finger Protein 10, belongs to a family of transcription factors characterized by the presence of zinc finger motifs that facilitate DNA binding. The recognition of ZNF10's role has expanded significantly in recent years, particularly in the context of gene regulation, cellular differentiation, and disease pathology, including various cancers and neurological disorders. Research has shown that ZNF10 can modulate transcriptional networks by interacting with specific DNA sequences, thereby influencing the expression of target genes involved in critical cellular processes. Additionally, studies have indicated that aberrations in ZNF10 expression or function can contribute to the dysregulation of these processes, making it a potential biomarker and therapeutic target. The development of recombinant ZNF10 proteins has become pivotal for elucidating its biochemical properties and functional mechanisms in vitro and in vivo. By producing ZNF10 as a recombinant protein, researchers can perform a variety of assays to investigate its interactions with DNA and other proteins, understand its role in transcriptional regulation, and explore its potential involvement in the pathogenesis of diseases. Overall, the study of ZNF10 as a recombinant protein not only enhances our understanding of its fundamental biological functions but also opens avenues for its application in therapeutic strategies aimed at correcting the dysregulation associated with its malfunction.
